Core Viewpoint - The stock of Jinxin Fertility (01951) has shown a positive trend, with a rise of over 7% during the trading session and currently up by 5.28%, indicating strong market interest and confidence in the company's performance [1] Group 1: Company Performance - Jinxin Fertility's fourth-quarter operational data continues to show improvement, following a positive trend from the previous three quarters, demonstrating resilient business operations [1] - By the end of 2025, the cumulative number of IVF egg retrieval cycles is expected to see a reduction in year-on-year decline from 5.2% in the previous three quarters to 1.4%, indicating a significant recovery in performance [1] Group 2: Market Context - As a leading player in the domestic assisted reproductive industry, Jinxin Fertility is poised to benefit from the ongoing enhancement of fertility policies in China and the United States, with expectations for marginal performance improvement in 2026 from a low base [1]
港股异动 | 锦欣生殖(01951)盘中涨超7% 公司为国内辅助生殖龙头 运营数据延续改善态势